Theodore R. Schroeder, President, CEO at CADENCE PHARMACEUTICALS INC (CADX), sold 50,000 shares at $8.35 ($418K) on 2010-09-30, disclosed to the SEC on 2010-10-04.
Scheduled sale ($418k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.35 | 40,703 | $340K | 81.4% |
| 2 | $8.35 | 9,297 | $78K | 18.6% |
| Total | $8.35 avg | 50,000 | $418K | 100% |
| Filing → |
| NBRV | BUY | 2019-08-28 | $90K | — | Filing → |
| CADX | BUY | 2011-05-17 | $120K | — | Filing → |
| CADX | SELL | 2010-07-01 | $350K | — | Filing → |